4.7 Article

Mechanism by which metformin reduces glucose production in type 2 diabetes

期刊

DIABETES
卷 49, 期 12, 页码 2063-2069

出版社

AMER DIABETES ASSOC
DOI: 10.2337/diabetes.49.12.2063

关键词

-

资金

  1. NCRR NIH HHS [M01 RR000125] Funding Source: Medline
  2. NIDDK NIH HHS [R01 DK014507, R01 DK-14507, P30 DK-45735, R01 DK049230, P30 DK045735, R01 DK-49230, K23 DK002734-01, K23 DK002734] Funding Source: Medline

向作者/读者索取更多资源

To examine the mechanism by which metformin lowers endogenous glucose production in type 2 diabetic patients, we studied seven type 2 diabetic subjects, with fasting hyperglycemia (15.5 +/- 1.3 mmol/l), before and after 3 months of metformin treatment. Seven healthy subjects, matched for sex, age, and BMI,served as control subjects. Rates of net hepatic glycogenolysis, estimated by C-13 nuclear magnetic resonance spectroscopy, were combined with estimates of contributions to glucose production of gluconeogenesis and glycogenolysis, measured by labeling of blood glucose by H-2 from ingested (H2O)-H-2. Glucose production was measured using [6,6-H-2(2)]glucose. The rate of glucose production was twice as high in the diabetic subjects as in control subjects (0.70 +/- 0.05 vs. 0.36 +/- 0.03 mmol m(-2) min(-1), P < 0.0001). Metformin reduced that rate by 24% (to 0.53 +/- 0.03 mmol.m(-2).min(-1), P = 0.0009) and fasting plasma glucose concentration by 30% (to 10.8 +/- 0.9 mmol/l, P = 0.0002). The rate of gluconeogenesis was three times higher in the diabetic subjects than in the control subjects (0.59 +/- 0.03 vs. 0.18 +/- 0.03 mmol.m(-2). min(-1)) and metformin reduced that rate by 36% (to 0.38 +/- 0.03 mmol.m(-2).min(-1), P = 0.01). By the (H2O)-H-2 method, there was a twofold increase in rates of gluconeogenesis in diabetic subjects (0.42 +/- 0.04 mmol.m(-2).min(-1)), which decreased by 33% after metformin treatment (0.28 +/- 0.03 mmol.m(-2).min(-1), P = 0.0002). There was no glycogen cycling in the control subjects, but in the diabetic subjects, glycogen cycling contributed to 25% of glucose production and explains the differences between the two methods used, In conclusion, patients with poorly controlled type 2 diabetes have increased rates of endogenous glucose production, which can be attributed to increased rates of gluconeogenesis. Metformin lowered the rate of glucose production in these patients through a reduction in gluconeogenesis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据